Hudson KE, Arnold Egloff SA, Goyal RK, Cai B, Caro N, Frost M, Darrien Ansquer V, Davis KL. Real-world assessment of clinical outcomes associated with immunotherapy and chemotherapy in patients with non–small cell lung cancer with brain metastases and MET exon 14 skipping mutations treated in US community centers. Poster presented at the 2022 North America Conference on Lung Cancer; September 25, 2022. Chicago, IL.

Abstract not available at this time.

Share on: